Key facts
- This page summarizes Jerome J. Lande's Form 4 filing for CONMED Corp (CNMD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2024, 21:17.
Jerome J. Lande - 31 May 2024 Form 4 Insider Report for CONMED Corp (CNMD)
- Reporting relationship
- Director
- Issuer ticker
- CNMD
- Reported as of
- 31 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2024, 21:17:43 UTC
- Prior SEC filing
- 02 Apr 2024
- Next SEC filing
- 02 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Fistek for Jerome J. Lande by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jerome J. Lande filed Form 4 for CONMED Corp (CNMD) on 04 Jun 2024.
Change
- Previous filing in this sequence was filed on 02 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +302
- Change %
- +8.5%
- Price
- $0.000000
- Shares after
- 3,856
- Date
- 31 May 2024
- Ownership
- Direct
CNMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 31 May 2024
- Ownership
- Coppersmith Capital Management, LLC
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CNMD
transaction
Derivative
Rsus (restricted Stock Units)
Options Exercise
- Transaction value
- $0
- Shares
- -302
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 31 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 302
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Mr. Lande, as a Managing Member of Coppersmith Capital Management, LLC ("Coppersmith Capital"), may be deemed the beneficial owner of the 1,630,800 shares of Common Stock, $0.01 par value ("Common Stock") beneficially owned by Coppersmith Capital, the Investment Adviser to a number of investment funds or managed accounts. Mr. Lande disclaims beneficial ownership of such Common Stock except to the extent of his pecuniary interest therein.
Footnote F2
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.